Marella Thorell - Mar 25, 2024 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
EVP and Chief Financial Officer
Signature
/s//Thomas J. DesRosier, Attorney-in-Fact for Marella Thorell
Stock symbol
MCRB
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 04:20 PM
Previous filing
Nov 8, 2023
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Options (right to buy) Award $0 +700K $0.00 700K Mar 25, 2024 Common Stock 700K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on March 25, 2025. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

EVP and Chief Financial Officer